Comparison of the biochemical and hematological profiles of patients with COVID-19 in their different outcomes: Hospital discharge and death
DOI:
https://doi.org/10.33448/rsd-v11i2.25772Keywords:
SARS-CoV-2; COVID-19; Biomarkers; Prognosis.Abstract
Introduction: The virus that causes COVID-19, SARS-CoV-2, has as its main focus of involvement the respiratory tract, even today with many patients evolving to the most severe form. Therefore, it is necessary to identify early signs and symptoms of COVID-19, as well as possible risk factors and signs of poor prognosis involved in the progression of the disease. Objective: The present study aimed to evaluate biochemical, hematological and coagulation tests in patients diagnosed with COVID-19 in order to identify a prognostic pattern for the outcomes of hospital discharge and death from a descriptive data compilation from a public repository. Methodology: Data from patients seen between February 26 and June 27, 2020 at Hospital Sírio-Libanês, made available by a public repository, were divided into two categories for analyses. Demographic data (gender, age and city where the patient resides) and clinical/laboratory data (test results) were analyzed, including the outcome (discharge or death). Results: Older age and male gender were more associated with the outcome of death. D-dimer and blood glucose were higher in the death group, while GFR worsened in both groups and APTT, total bilirubin, serum creatinine, blood glucose, D-dimer and CRP increased in the outcome only of patients who died, the latter reduced in the "hospital discharge" group. Moreover, there were lower rates of hemoglobin, erythrocytes and hematocrit, platelets and lymphocytes, as well as increased leukocytes, neutrophils and basophils in the group of patients who died. Conclusion: The variations found in biochemical parameters suggest especially that hyperglycemia is associated with more severe cases, while the analysis of inflammation confirms by CRP that this condition was more exacerbated in patients who died. In coagulation analysis, increased D-dimer was associated with more severe cases, and in hematology, the results reflect a higher risk of anemia and systemic inflammatory response.
References
Alves, B. / O. / O.-M. (n.d.). Novo Coronavírus (Covid-19): informações básicas | Biblioteca Virtual em Saúde MS. https://bvsms.saude.gov.br/novo-coronavirus-covid-19-informacoes-basicas/
Ashour, H. M., Elkhatib, W. F., Rahman, M. M., & Elshabrawy, H. A. (2020). Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens, 9(3), 186. doi:10.3390/pathogens9030186
Badawi, A., & Ryoo, S. G. (2016). Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. International journal of infectious diseases. IJID: official publication of the International Society for Infectious Diseases, 49, 129–133. doi:https://doi.org/10.1016/j.ijid.2016.06.015
Baloch, S., Baloch, M. A., Zheng, T., & Pei, X. (2020). The Coronavirus Disease 2019 (COVID-19) Pandemic. The Tohoku journal of experimental medicine, 250(4), 271–278. doi:https://doi.org/10.1620/tjem.250.271
Berenguer, J., Ryan, P., Rodríguez-Baño, J., Jarrín, I., Carratalà, J., Pachón, ...Arriba, J. R.. (2020). Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clinical microbiology and infection: the official publication of the European Society of
Clinical Microbiology and Infectious Diseases, 26(11), 1525–1536. doi: https://doi.org/10.1016/j.cmi.2020.07.024
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J. L., Navis, G. J., Gordijn, S. J....Van Goor, H. (2020). Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of pathology, 251(3), 228–248. doi: https://doi.org/10.1002/path.5471
Callender, L. A., Curran, M., Bates, S. M., Mairesse, M., Weigandt, J., & Betts, C. J. (2020). The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Frontiers in immunology, 11, 1991. doi: https://doi.org/10.3389/fimmu.2020.01991
Casqueiro, J., Casqueiro, J., & Alves, C. (2012). Infections in patients with diabetes mellitus: A review of pathogenesis. Indian journal of endocrinology and metabolism, 16 Suppl 1(Suppl1), S27–S36. doi:https://doi.org/10.4103/2230-8210.94253
Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P. P., Meyerholz, D. K., & Perlman, S. (2017). Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. Journal of immunology (Baltimore, Md: 1950), 198(10), 4046–4053. doi:https://doi.org/10.4049/jimmunol.1601896
Chen, R., Sang, L., Jiang, M., et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020;146(1):89–100. doi: 10.1016/j.jaci.2020.05.003
Chen, J., Qi, T., Liu, L., Ling, Y., Qian, Z., Li, T., Li, F., …Lu, H. (2020). Clinical progression of patients with COVID-19 in Shanghai, China. The Journal of infection, 80(5), e1–e6. doi:https://doi.org/10.1016/j.jinf.2020.03.004
Chen, J., Wu, C., Wang, X., Yu, J., & Sun, Z. (2020). The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis. Frontiers in endocrinology, 11, 574541. doi: https://doi.org/10.3389/fendo.2020.574541
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., …Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223). doi: https://doi.org/10.1016/s0140-6736(20)30211-7
Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D., Robert, A., & Noubiap, J. J. (2020). A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomarker research, 8, 37. doi:https://doi.org/10.1186/s40364-020-00217-0
Deng, Y., Liu, W., Liu, K., Fang, Y. Y., Shang, J., Zhou, L., …Liu, H. G. (2020). Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chinese medical journal, 133(11), 1261–1267. doi:https://doi.org/10.1097/CM9.0000000000000824
Desiderio, V.L., Fabio, V., Cárnio, E.C., Silva, H.B. & Marchi-Alves, L.M. (2021). Variáveis associadas ao desfecho clínico de pacientes hospitalizados por COVID-19. Rev Med (São Paulo), 100(5), 431-41. doi:http://dx.doi.org/10.11606/issn.1679-9836.v100i5p431-441
Djakpo, D. K., Wang, Z., Zhang, R., Chen, X., Chen, P., & Antoine, M. (2020). Blood routine test in mild and common 2019 coronavirus (COVID-19) patients. Bioscience reports, 40(8), BSR20200817. doi:https://doi.org/10.1042/BSR20200817
Fapesp. COVID-19 Data Sharing/BR. Disponível em: https://repositoriodatasharingfapesp.uspdigital.usp.br/
Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E., & Zafrani, L. (2020). Acute kidney injury in critically ill patients with COVID-19. Intensive care medicine, 46(7), 1339–1348. doi:https://doi.org/10.1007/s00134-020-06153-9
Ge, H., Wang, X., Yuan, X., Xiao, G., Wang, C., Deng, T., Yuan, Q. & Xiao, X. (2020). The epidemiology and clinical information about COVID-19. European journal of clinical microbiology & infectious disease : official publication of the European Society of Clinical Microbiology, 39(6), 1011–1019. doi:https://doi.org/10.1007/s10096-020-03874-z
Gralinski, L. E., & Menachery, V. D. (2020). Return of the Coronavirus: 2019-nCoV. Viruses, 12(2), 135. doi:https://doi.org/10.3390/v12020135
Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J…Li, S. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382(18). doi:https://doi.org/10.1056/nejmoa2002032
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., …Lu, Z. (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA cardiology, 5(7), 811–818. doi:https://doi.org/10.1001/jamacardio.2020.1017
Hajek, V., Pasquet, F., Karkowski, L., Lachenal, F., Gerôme, P., & Pavic, M. (2011). Profil étiologique et pronostique des valeurs extrêmes (≥500 mg/L) de protéine C-réactive : étude rétrospective de 168 valeurs chez 113 patients. La Revue de Médecine Interne, 32(11), 663–668. doi:https://doi.org/10.1016/j.revmed.2011.04.001
Han, H., Yang, L., Liu, R., Liu, F., Wu, K. L., Li, J., Liu, X. H., & Zhu, C. L. (2020). Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clinical chemistry and laboratory medicine, 58(7), 1116–1120. doi:https://doi.org/10.1515/cclm-2020-0188
He, Y., Xie, M., Zhao, J., & Liu, X. (2020). Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD). Medical science monitor: international medical journal of experimental and clinical research, 26, e927212. doi:https://doi.org/10.12659/MSM.927212
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H.,...Pallansch, M. A. (2020). Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. The New England journal of medicine, 382(10), 929–936. doi:https://doi.org/10.1056/NEJMoa2001191
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., …Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395(10223), 497–506. doi:https://doi.org/10.1016/S0140-6736(20)30183-5
Ibrahim, I. M., Abdelmalek, D. H., Elshahat, M. E., & Elfiky, A. A. (2020). COVID-19 spike-host cell receptor GRP78 binding site prediction. The Journal of infection, 80(5), 554–562. doi:https://doi.org/10.1016/j.jinf.2020.02.026
Jaillon, S., Berthenet, K., & Garlanda, C. (2019). Sexual Dimorphism in Innate Immunity. Clinical reviews in allergy & immunology, 56(3), 308–321. doi:https://doi.org/10.1007/s12016-017-8648-x
Jain, V., & Yuan, J. M. (2020). Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. International journal of public health, 65(5), 533–546. doi:https://doi.org/10.1007/s00038-020-01390-7
Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W. & Duan, G. (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 12(4). doi: https://doi.org/10.3390/v12040372
Kellum, J. A., van Till, J., & Mulligan, G. (2020). Targeting acute kidney injury in COVID-19. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 35(10), 1652–1662. doi:https://doi.org/10.1093/ndt/gfaa231
Landry, A., Docherty, P., Ouellette, S., & Cartier, L. J. (2017). Causes and outcomes of markedly elevated C-reactive protein levels. Canadian family physician Medecin de famille canadien, 63(6), e316–e323.
Lei, F., Liu, Y. M., Zhou, F., Qin, J. J., Zhang, P., Zhu, L., …Yuan, Y. (2020). Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology (Baltimore, Md.), 72(2), 389–398. doi: https://doi.org/10.1002/hep.31301
Li, H., Liu, L., Zhang, D., Xu, J., Dai, H., Tang, N., Su, X. & Cao, B. (2020). SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 9;395(10235):1517-1520 . doi: https://doi.org/10.1016/S0140-6736(20)30920-X
Liu, Y., Du, X., Chen, J., Jin, Y., Peng, L., Wang, H., …Zhao, Y. (2020). Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. The Journal of infection, 81(1), e6–e12. doi: https://doi.org/10.1016/j.jinf.2020.04.002
Maciel, E.L., Jabor, P., Goncalves Júnior, E., Tristão-Sá, R., Lima, RCD., Reis-Santos, B., ...Zandonade, E. (2020). Fatores associados ao óbito hospitalar por COVID-19 no Espírito Santo, 2020. Epidemiologia E Serviços de Saúde, 29, e2020413. doi:https://doi.org/10.1590/s1679-49742020000400022
Mikami, T., Miyashita, H., Yamada, T., Harrington, M., Steinberg, D., Dunn, A., & Siau, E. (2021). Risk Factors for Mortality in Patients with COVID-19 in New York City. Journal of general internal medicine, 36(1), 17–26. doi:https://doi.org/10.1007/s11606-020-05983-z
Mizumoto, K., & Chowell, G. (2020). Estimating Risk for Death from Coronavirus Disease, China, January-February 2020. Emerging infectious diseases, 26(6), 1251–1256. doi:https://doi.org/10.3201/eid2606.200233
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020). Biomarkers associated with COVID-19 disease progression. Critical reviews in clinical laboratory sciences, 57(6), 389–399. doi:https://doi.org/10.1080/10408363.2020.1770685
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y.,…Tian, D.S. (2020). Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 71(15), 762–768. doi:https://doi.org/10.1093/cid/ciaa248
Reade, M.C., Weissfeld, L., Angus, D.C., Kellum, J.A. & Milbrandt, EB. (2010). The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm Med; 10:15. doi: https://doi.org/ 10.1186/1471-2466-10-15
Shi, Y., Wang, Y., Shao C., Huang, J., Gan, J., Huang, X., …Melino, G. (2020). COVID-19 infection: the perspectives on immune responses. Cell Death Differ.;23:1–4. doi: https://doi.org/ 10.1038/s41418-020-0530-3
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020). Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet. Infectious diseases, 20(4), 425–434. doi:https://doi.org/10.1016/S1473-3099(20)30086-4
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., …Huang, C. (2020). Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA cardiology, 5(7), 802–810. doi:https://doi.org/10.1001/jamacardio.2020.0950
Snijders, D., Schoorl, M., Schoorl, M., Bartels, P. C., van der Werf, T. S., & Boersma, W. G. (2012). D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. European journal of internal medicine, 23(5), 436–441. doi:https://doi.org/10.1016/j.ejim.2011.10.019
Sousa, G., Garces, T. S., Cestari, V., Florêncio, R. S., Moreira, T., & Pereira, M. (2020). Mortality and survival of COVID-19. Epidemiology and infection, 148, e123. doi:https://doi.org/10.1017/S0950268820001405
Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis. JTH, 18(4), 844–847. doi: https://doi.org/10.1111/jth.14768
Teich, V.D., Klajner, S., Almeida, F.A.S., Dantas, A.C.B., Laselva, C.R., Torritesi, M.G., …Neto, M.C. (2020). Características epidemiológicas e clínicas dos pacientes com COVID-19 no Brasil. Einstein (São Paulo), 18, 1-7. doi:https://10.31744/einstein_journal/2020AO6022
Tian, W., Jiang, W., Yao, J., Nicholson, C. J., Li, R. H., Sigurslid, H. H., ...Malhotra, R. (2020). Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. Journal of medical virology, 92(10), 1875–1883. doi:https://doi.org/10.1002/jmv.26050
Wang, B., Li, R., Lu, Z., & Huang, Y. (2020). Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging, 12(7), 6049–6057. https://doi.org/10.18632/aging.103000
Wang, C., Deng, R., Gou, L., Fu, Z., Zhang, X., Shao, F., …Li, C. (2020a). Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Annals of Translational Medicine, 8(9), 593–593. doi: https://doi.org/10.21037/atm-20-3391
Wang, C., Zhang, H., Cao, X., Deng, R., Ye, Y., Fu, Z., …Lu, Z. (2020b). Red cell distribution width (RDW): a prognostic indicator of severe COVID-19. Annals of translational medicine, 8(19), 1230. doi:https://doi.org/10.21037/atm-20-6090
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., …Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. doi: https://doi.org/10.1001/jama.2020.1585
Wang, K., Zuo, P., Liu, Y., Zhang, M., Zhao, X., Xie, S., Zhang, H., Chen, X., & Liu, C. (2020). Clinical and Laboratory Predictors of In-hospital Mortality in Patients With Coronavirus Disease-2019: A Cohort Study in Wuhan, China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 71(16), 2079–2088. doi: https://doi.org/10.1093/cid/ciaa538
World Health Organization. (2021). WHO COVID-19 dashboard. World Health Organization. https://covid19.who.int/
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., …Song, Y. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA internal medicine, 180(7), 934–943. doi: https://doi.org/10.1001/jamainternmed.2020.0994
Xavier, A. R., Silva, J. S., Almeida, J. P. C. L., Conceição, J. F. F., Lacerda, G. S., & Kanaan, S. (2020). COVID-19: clinical and laboratory manifestations in novel coronavirus infection. Jornal Brasileiro de Patologia E Medicina Laboratorial. doi: https://doi.org/10.5935/1676-2444.20200049
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., ... Shang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet. Respiratory medicine, 8(5), 475–481. doi:https://doi.org/10.1016/S2213-2600(20)30079-5
Yi, Y., Lagniton, P., Ye, S., Li, E., & Xu, R. H. (2020). COVID-19: what has been learned and to be learned about the novel coronavirus disease. International journal of biological sciences, 16(10), 1753–1766. doi: https://doi.org/10.7150/ijbs.45134
Yuki K, Fujiogi M & Koutsogiannaki S. (2020). COVID-19 pathophysiology: A review. Clin Immunol Orlando Fla. 215:108427. doi: https://doi.org/10.1016/j.clim.2020.108427
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., ... Zhang, S. (2020). Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 382(17):e38. doi: https://doi.org/ 10.1056/NEJMc2007575
Zhang, C., Shi, L., & Wang, F. S. (2020). Liver injury in COVID-19: management and challenges. The lancet. Gastroenterology & hepatology, 5(5), 428–430. doi: https://doi.org/10.1016/S2468-1253(20)30057-1
Zhang, J. J., Dong, X., Cao, Y. Y., Yuan, Y. D., Yang, Y. B., Yan, Y., …Gao, Y. D. (2020). Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 75(7), 1730–1741. doi: https://doi.org/10.1111/all.14238
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., …Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 395(10229), 1054–1062. doi: https://doi.org/10.1016/S0140-6736(20)30566-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Gabriel Frateschi Rebello da Silva; Alexandra Alejo Callante; Débora Pereira do Nascimento; Iago Portolani de Araújo; Carolina Heitmann Mares Azevedo Ribeiro; Ana Cristina Lo Prete
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
